Did cathelicidins, a family of multifunctional host-defense peptides, arise from a cysteine protease inhibitor?

Trends in Microbiology

Volumn 16, Issue 8, 2008, Pages 353-360

  Zhu, Shunyi ^a  

^a INSTITUTE OF ZOOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN; CATHELIN; CYSTATIN;

ADAPTIVE IMMUNITY; AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; GENE STRUCTURE; HOST RESISTANCE; HUMAN; INNATE IMMUNITY; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PEPTIDE ANALYSIS; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; SEQUENCE ALIGNMENT; SPECIES DIFFERENCE;

AMINO ACID SEQUENCE; ANIMALS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CYSTEINE PROTEINASE INHIBITORS; EVOLUTION, MOLECULAR; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT;

EID: 48149089791     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tim.2008.05.007     Document Type: Article

References (45)

1. Zanetti M. The role of cathelicidins in the innate host defenses of mammals. Curr. Issues Mol. Biol. 7 (2005) 179-196
2. Chang C.I., et al. Two cathelicidin genes are present in both rainbow trout (Oncorhynchus mykiss) and Atlantic Salmon (Salmo salar). Antimicrob. Agents Chemother. 50 (2006) 185-195
3. Uzzell T., et al. Hagfish intestinal antimicrobial peptides are ancient cathelicidins. Peptides 24 (2003) 1655-1667
4. Zaiou M., and Gallo R.L. Cathelicidins, essential gene-encoded mammalian antibiotics. J. Mol. Med. 80 (2002) 549-561
5. Tomasinsig L., and Zanetti M. The cathelicidins - structure, function and evolution. Curr. Protein Pept. Sci. 6 (2005) 23-34
6. Yu J., et al. Host defense peptide LL-37, in synergy with inflammatory mediator IL-1β, augments immune responses by multiple pathways. J. Immunol. 179 (2007) 7684-7691
7. Yang D., et al. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med. 192 (2000) 1069-1074
8. Xiao Y., et al. Identification and functional characterization of three chicken cathelicidins with potent antimicrobial activity. J. Biol. Chem. 281 (2006) 2858-2867
9. Hedges S.B. The origin and evolution of model organisms. Nat. Rev. Genet. 3 (2002) 838-849
10. Zhao C., et al. Identification of a new member of the protegrin family by cDNA cloning. FEBS Lett. 346 (1994) 285-288
11. Agerberth B. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 195-199
12. Janowski R. Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping?. Nat. Struct. Biol. 8 (2001) 316-320
13. Dieckmann T. The structures of native phosphorylated chicken cystatin and of a recombinant unphosphorylated variant in solution. J. Mol. Biol. 234 (1993) 1048-1059
14. Stubbs M.T. The refined 2.4 Å X-ray crystal structure of recombinant human stefin B in complex with the cysteine proteinase papain: a novel type of proteinase inhibitor interaction. EMBO J. 9 (1990) 1939-1947
15. Yang Y. NMR structure of the cathelin-like domain of the protegrin-3 precursor. Biochemistry 42 (2003) 4669-4680
16. Müller-Esterl W., et al. Genealogy of mammalian cysteine proteinase inhibitors. Common evolutionary origin of stefins, cystatins and kininogens. FEBS Lett. 191 (1985) 221-226
17. Rzychon M., et al. Modes of inhibition of cysteine proteases. Acta Biochim. Pol. 51 (2004) 861-873
18. Alvarez-Fernandez M., et al. Crystal structure of human cystatin D, a cysteine peptidase inhibitor with restricted inhibition profile. J. Biol. Chem. 280 (2005) 18221-18228
19. Zaiou M., et al. Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL37) prosequence. J. Invest. Dermatol. 120 (2003) 810-816
20. Zhu S., et al. Activation of cathepsin L by the cathelin-like domain of protegrin-3. Mol. Immunol. 45 (2008) 2531-2536
21. Zhu S. Positive selection targeting the cathelin-like domain of the antimicrobial cathelicidin family. Cell. Mol. Life Sci. 65 (2008) 1285-1294
22. Betts M.J., et al. Exon structure conservation despite low sequence similarity: a relic of dramatic events in evolution?. EMBO J. 20 (2001) 5354-5360
23. Boman H.G. Antibacterial peptides: basic facts and emerging concepts. J. Intern. Med. 254 (2003) 197-215
24. Grunclová L., et al. Two secreted cystatins of the soft tick Ornithodoros moubata: differential expression pattern and inhibitory specificity. Biol. Chem. 387 (2006) 1635-1644
25. Weatherall D.J., and Clegg J.B. Recent developments in the molecular genetics of human hemoglobin. Cell 16 (1979) 467-479
26. Sverdlov A.V., et al. Preferential loss and gain of introns in 3′ portions of genes suggests a reverse-transcription mechanism of intron insertion. Gene 338 (2004) 85-91
27. Sorek R. The birth of new exons: mechanisms and evolutionary consequences. RNA 13 (2007) 1603-1608
28. Edgar R.C. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32 (2004) 1792-1797
29. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 415 (2002) 389-395
30. Loose C., et al. A linguistic model for the rational design of antimicrobial peptides. Nature 443 (2006) 867-869
31. Belov K., et al. Characterization of the opossum immune genome provides insights into the evolution of the mammalian immune system. Genome Res. 17 (2007) 982-991
32. Froy O., and Gurevitz M. Arthropod and mollusk defensins - evolution by exon-shuffling. Trends Genet. 19 (2003) 684-687
33. Rodriguez de la Vega R.C., and Possani L.D. On the evolution of invertebrate defensins. Trends Genet. 21 (2005) 330-332
34. Yeaman M.R., and Yount N.Y. Unifying themes in host defence effector polypeptides. Nat. Rev. Microbiol. 5 (2007) 727-740
35. Patthy L. Genome evolution and the evolution of exon-shuffling - a review. Gene 238 (1999) 103-114
36. Zhang X.H.F., and Chasin L.A. Comparison of multiple vertebrate genomes reveals the birth and evolution of human exons. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 13427-13432
37. Bjorck L., et al. Bacterial growth blocked by a synthetic peptide based on the structure of a human proteinase inhibitor. Nature 337 (1989) 385-386
38. Hancock R.E. Peptide antibiotics. Lancet 349 (1997) 418-422
39. Kasahara M., et al. On the origins of the adaptive immune system: novel insights from invertebrates and cold-blooded vertebrates. Trends Immunol. 25 (2004) 105-111
40. Kopitar-Jerala N. The role of cystatins in cells of the immune system. FEBS Lett. 580 (2006) 6295-6301
41. Vray B., et al. Immunomodulatory properties of cystatins. Cell. Mol. Life Sci. 59 (2002) 1503-1510
42. Hoffmann J.A., and Reichhart J.M. Drosophila innate immunity: an evolutionary perspective. Nat. Immunol. 3 (2002) 121-126
43. Kimbrell D.A., and Beutler B. The evolution and genetics of innate immunity. Nat. Genet. 2 (2001) 256-267
44. Bulet P., et al. Anti-microbial peptides: from invertebrates to vertebrates. Immunol. Rev. 198 (2004) 169-184
45. De Smet K., and Contreras R. Human antimicrobial peptides: defensins, cathelicidins and histatins. Biotechnol. Lett. 27 (2005) 1337-1347